CONGRESSIONAL FDA OVERSIGHT EXPERIENCE TO DWINDLE IN LIGHT OF STAFF CUTS
This article was originally published in The Tan Sheet
Executive Summary
CONGRESSIONAL FDA OVERSIGHT EXPERIENCE TO DWINDLE IN LIGHT OF STAFF CUTS anticipated in key committees and subcommittees that oversee the agency. The new Republican House leadership said it intends to "review every aspect of the current organizational structure of the House," and may consider trimming the large number of committees and their staffs. The change of control in the House will lead to the dismantling of the large, well- established committee staffs as well as the replacement of the Democratic committee chairs. At Energy & Commerce, Rep. John Dingell's (D-Mich.) aggressive investigative staff will be subject to large cuts.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: